• For Researchers

The promise of proteomics for cancer prevention

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

10 September 2024

• For Researchers

Failing the most vulnerable

Meeting the needs of children and young people with cancer will mean facing the market’s failure to get new drugs to the clinic head-on says Sam Daems... Meeting the needs of children and young people with cancer will mean facing the market’s failure to get new drugs to the clinic head-on says Sam Daems...

6 September 2024

• For Researchers

Dissolving the boundaries – physics and biology come together for cancer

Stephen Smye talks about how to get the balance between deep disciplinary knowledge and interdisciplinary approaches right... Stephen Smye talks about how to get the balance between deep disciplinary knowledge and interdisciplinary approaches right...

9 August 2024

• For Researchers

Exploring the promise of decentralised cancer clinical trials

Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges... Can decentralised trials become mainstream for cancer? The benefits can be manifold, but so can the challenges...

31 July 2024

• For Researchers

The great escape artist – how tracking co-evolution could improve immunotherapy

We need to understand how tumours and the immune system co-evolve to target cancer cells at their most vulnerable... We need to understand how tumours and the immune system co-evolve to target cancer cells at their most vulnerable...

24 July 2024

• For Researchers

Introducing our new clinical research funding

Head of clinical research Dr Graham Cadwallader, tells us about the bold changes we are making to the way we fund clinical research... Head of clinical research Dr Graham Cadwallader, tells us about the bold changes we are making to the way we fund clinical research...

17 July 2024

• For Researchers

A winding road – the many adventures of a promising ADC

From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development? From obscure enzymes to the common cold… just how did spin out Myricx Bio put their ADC on the path to clinical development?

9 July 2024